Zdrowie i gospodarka · 12/09/2011
FDA Announces Public Meeting to Discuss Reauthorization of Prescription Drug User Fee Act
The FDA is holding a public meeting to gather public input on proposed recommendations for reauthorizing the Prescription Drug User Fee Act, which authorizes the agency to collect user fees for reviewing human drug applications from FY 2013 to 2017.
Source: Federal Register — Health and Human ServicesOpen original release →